Macmillan Cancer Support is expecting a £175million drop in income by the end of 2022 because of Covid-19. Announcing the cuts, chief executive Lynda Thomas said: “The scale and nature of the coronavirus has had a catastrophic impact on our finances that no one could have anticipated.
“Our people are at the heart of everything we do and we are absolutely committed to ensuring all impacted colleagues are treated with compassion and care.
“Despite the disruption and financial challenges brought on by the pandemic, our top priority is helping everyone with cancer live life as fully as they can.
“Right now, someone is diagnosed every 90 seconds in the UK and we call on both the Government and the public to help ensure that cancer doesn’t become the forgotten ‘C’ of the pandemic.”
The charity furloughed almost a third of staff, stopped non-essential spending and closed offices.
Less than two weeks ago Cancer Research UK warned up to 1,500 scientists may be made redundant if the funding crisis continues.
